The Scientific and Regulatory Affairs Committee (SRAC) superseded the Scientific and Technical Committee (S&TC), as it was felt that the Association should not only be concerned with the scientific aspects of our work but also in the regulatory and industrial aspects.
We are all aware of the changes within our profession and this is especially so in scientific activities as the amount of research/development in Clinical Laboratories has diminished significantly over recent years. Even the members who undertake research are generally members of “research associations” and tend to present their work in that forum which more represents their research peers. The “Golden Era” in this area was during the development of the QAP. This early work by the S&TC led to the formation of RCPA QAP Pty Ltd for which the AACB now acts as a key advisory body. For many years the various AACB Working Parties have supported the QAP, firstly by doing the pilot work for the development of new QA Programs and then in a continuing specialist advisory role. This will continue and we are always willing to support members who wish to develop further programs on new analytes.
One of the roles of the SRAC will be to disseminate information from organisations such as IFCC, NCCLS, IRMM, CDC, WHO and other similar bodies. The AACB is increasingly being asked for an opinion on various regulatory issues by organisations such as NATA, NPAAC and the Federal Department of Health. This role needs to be fostered, as it is a way of increasing the profile of the Association. The other role will be to prepare Position and Working Papers on various important topics for example Point-of-Care Testing. We also have many members with considerable expertise in Quality Assurance and Quality Control but have never really tapped this expertise in a way that could be of significant benefit to our members and other professional organisations. The AACB website is ideal for making this information available and thereby increasing the profile of the AACB.